Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Jangli Amla (Phyllanthus emblica) delivers therapeutic effects through high concentrations of vitamin C and tannins, particularly emblicanin A and B, which modulate immune function and hepatic detoxification pathways. The fruit's gallic acid content activates antioxidant enzyme systems including superoxide dismutase and catalase.
Reported Benefits (Provisional)
Origin & History
Jangli Amla (Phyllanthus emblica), also known as Indian Gooseberry, is a revered fruit native to the tropical and subtropical forests of India, Nepal, and Southeast Asia. This potent superberry is celebrated for its exceptional vitamin C content and diverse array of phytochemicals, making it a cornerstone for immune support, detoxification, and longevity in functional nutrition.
Research Narrative (Provisional)
Extensive research, including studies published on PubMed and ScienceDirect, validates Jangli Amla's potent immune-boosting and liver-detoxifying effects. Further investigations support its benefits for digestion, cardiovascular health, and cognitive function, positioning it as a well-researched superberry.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin C - Minerals: Potassium, magnesium, calcium - Phytochemicals/Bioactives: Flavonoids (quercetin, catechins), tannins, gallic acid, ellagic acid, carotenoids
Reported Mechanism (Provisional)
Jangli Amla's emblicanin A and B tannins inhibit lipid peroxidation while upregulating hepatic phase II detoxification enzymes including glutathione S-transferase. The fruit's ascorbic acid content (478-720mg per 100g) enhances neutrophil chemotaxis and lymphocyte proliferation. Gallic acid derivatives activate Nrf2 pathways, promoting endogenous antioxidant synthesis.
Clinical Narrative (Provisional)
Current clinical evidence specifically for Jangli Amla as a distinct variety remains limited, with most studies focusing on standard Phyllanthus emblica. Available research on P. emblica shows immune enhancement in trials of 60-120 participants over 8-12 weeks. Hepatoprotective effects have been documented in smaller pilot studies (n=30-45) measuring liver enzyme reductions of 15-25%. The evidence base requires expansion with larger, controlled trials specifically examining wild varieties.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.